US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 20.650
  • -0.140-0.67%
Close Nov 26 16:00 ET
  • 20.650
  • 0.0000.00%
Post 17:43 ET
13.12BMarket Cap20.30P/E (TTM)

Genmab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
17.57%5.54B
29.58%5.4B
46.19%4.14B
13.57%16.47B
-7.36%4.76B
15.29%4.71B
31.85%4.17B
33.74%2.83B
72.33%14.51B
101.14%5.14B
Operating revenue
17.57%5.54B
29.58%5.4B
49.79%3.86B
14.05%15.61B
-20.72%3.9B
24.66%4.71B
31.85%4.17B
29.99%2.58B
73.56%13.69B
105.22%4.91B
Cost of revenue
245.57%273M
804.76%190M
185M
226M
126M
79M
21M
0
0
0
Gross profit
13.68%5.27B
25.65%5.21B
39.66%3.96B
12.02%16.25B
-9.81%4.63B
13.36%4.63B
4.15B
2.83B
72.33%14.51B
5.14B
Operating expense
6.78%3.15B
26.72%3.4B
30.62%3.16B
32.64%10.93B
12.49%2.88B
36.73%2.95B
39.95%2.68B
50.59%2.42B
50.77%8.24B
41.55%2.56B
Selling and administrative expenses
0.58%865M
8.10%894M
26.78%857M
23.21%3.3B
1.41%934M
28.36%860M
30.65%827M
49.56%676M
108.57%2.68B
79.88%921M
Research and development costs
9.34%2.28B
35.02%2.5B
32.11%2.3B
37.18%7.63B
18.71%1.95B
40.51%2.09B
44.54%1.85B
51.00%1.74B
33.03%5.56B
26.43%1.64B
Operating profit
25.76%2.12B
23.71%1.82B
92.09%801M
-15.09%5.32B
-32.00%1.75B
-12.74%1.69B
17.72%1.47B
-18.87%417M
112.22%6.27B
246.10%2.58B
Net non-operating interest income expense
-38.72%144M
35.15%273M
54.84%288M
200.99%912M
114.07%289M
158.24%235M
348.89%202M
481.25%186M
64.67%303M
321.88%135M
Non-operating interest income
-33.61%162M
28.63%292M
53.65%295M
189.81%939M
90.71%267M
151.55%244M
345.10%227M
433.33%192M
64.47%324M
300.00%140M
Non-operating interest expense
100.00%18M
-24.00%19M
16.67%7M
28.57%27M
-540.00%-22M
50.00%9M
316.67%25M
50.00%6M
61.54%21M
66.67%5M
Other net income (expense)
-172.53%-544M
58.33%38M
286.05%627M
-258.93%-596M
51.68%-1.03B
-40.00%750M
-97.99%24M
-610.61%-337M
-51.98%375M
-1,810.40%-2.14B
Gain on sale of security
-170.27%-527M
791.67%214M
286.05%627M
-258.93%-596M
51.68%-1.03B
-40.00%750M
-97.99%24M
-610.61%-337M
-51.98%375M
-1,810.40%-2.14B
Special income (charges)
---17M
---176M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--17M
--176M
----
----
----
--0
--0
----
----
----
Income before tax
-35.62%1.72B
25.56%2.13B
545.11%1.72B
-18.83%5.64B
76.05%1.01B
-18.40%2.67B
-31.94%1.69B
-56.54%266M
77.26%6.95B
-36.51%572M
Income tax
-19.96%453M
100.28%719M
598.21%391M
-13.93%1.29B
424.14%304M
-17.97%566M
-39.97%359M
-61.90%56M
55.36%1.49B
-75.42%58M
Net income
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
84.38%5.45B
-22.71%514M
Net income continuous Operations
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
84.38%5.45B
-22.71%514M
Minority interest income
Net income attributable to the parent company
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
84.38%5.45B
-22.71%514M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-39.83%1.27B
5.47%1.41B
530.95%1.33B
-20.18%4.35B
36.77%703M
-18.51%2.1B
-29.40%1.34B
-54.84%210M
84.38%5.45B
-22.71%514M
Basic earnings per share
-38.11%1.994
6.79%2.185
532.09%2.029
-20.08%6.664
36.20%1.076
-18.53%3.222
-29.13%2.046
-54.79%0.321
84.39%8.338
-22.32%0.79
Diluted earnings per share
-37.98%1.981
7.00%2.17
532.60%2.018
-20.06%6.602
36.86%1.062
-18.46%3.194
-29.24%2.028
-54.75%0.319
84.48%8.259
-22.79%0.776
Dividend per share
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 17.57%5.54B29.58%5.4B46.19%4.14B13.57%16.47B-7.36%4.76B15.29%4.71B31.85%4.17B33.74%2.83B72.33%14.51B101.14%5.14B
Operating revenue 17.57%5.54B29.58%5.4B49.79%3.86B14.05%15.61B-20.72%3.9B24.66%4.71B31.85%4.17B29.99%2.58B73.56%13.69B105.22%4.91B
Cost of revenue 245.57%273M804.76%190M185M226M126M79M21M000
Gross profit 13.68%5.27B25.65%5.21B39.66%3.96B12.02%16.25B-9.81%4.63B13.36%4.63B4.15B2.83B72.33%14.51B5.14B
Operating expense 6.78%3.15B26.72%3.4B30.62%3.16B32.64%10.93B12.49%2.88B36.73%2.95B39.95%2.68B50.59%2.42B50.77%8.24B41.55%2.56B
Selling and administrative expenses 0.58%865M8.10%894M26.78%857M23.21%3.3B1.41%934M28.36%860M30.65%827M49.56%676M108.57%2.68B79.88%921M
Research and development costs 9.34%2.28B35.02%2.5B32.11%2.3B37.18%7.63B18.71%1.95B40.51%2.09B44.54%1.85B51.00%1.74B33.03%5.56B26.43%1.64B
Operating profit 25.76%2.12B23.71%1.82B92.09%801M-15.09%5.32B-32.00%1.75B-12.74%1.69B17.72%1.47B-18.87%417M112.22%6.27B246.10%2.58B
Net non-operating interest income expense -38.72%144M35.15%273M54.84%288M200.99%912M114.07%289M158.24%235M348.89%202M481.25%186M64.67%303M321.88%135M
Non-operating interest income -33.61%162M28.63%292M53.65%295M189.81%939M90.71%267M151.55%244M345.10%227M433.33%192M64.47%324M300.00%140M
Non-operating interest expense 100.00%18M-24.00%19M16.67%7M28.57%27M-540.00%-22M50.00%9M316.67%25M50.00%6M61.54%21M66.67%5M
Other net income (expense) -172.53%-544M58.33%38M286.05%627M-258.93%-596M51.68%-1.03B-40.00%750M-97.99%24M-610.61%-337M-51.98%375M-1,810.40%-2.14B
Gain on sale of security -170.27%-527M791.67%214M286.05%627M-258.93%-596M51.68%-1.03B-40.00%750M-97.99%24M-610.61%-337M-51.98%375M-1,810.40%-2.14B
Special income (charges) ---17M---176M--------------0--0------------
-Less：Restructuring and merger&acquisition --17M--176M--------------0--0------------
Income before tax -35.62%1.72B25.56%2.13B545.11%1.72B-18.83%5.64B76.05%1.01B-18.40%2.67B-31.94%1.69B-56.54%266M77.26%6.95B-36.51%572M
Income tax -19.96%453M100.28%719M598.21%391M-13.93%1.29B424.14%304M-17.97%566M-39.97%359M-61.90%56M55.36%1.49B-75.42%58M
Net income -39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M84.38%5.45B-22.71%514M
Net income continuous Operations -39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M84.38%5.45B-22.71%514M
Minority interest income
Net income attributable to the parent company -39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M84.38%5.45B-22.71%514M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -39.83%1.27B5.47%1.41B530.95%1.33B-20.18%4.35B36.77%703M-18.51%2.1B-29.40%1.34B-54.84%210M84.38%5.45B-22.71%514M
Basic earnings per share -38.11%1.9946.79%2.185532.09%2.029-20.08%6.66436.20%1.076-18.53%3.222-29.13%2.046-54.79%0.32184.39%8.338-22.32%0.79
Diluted earnings per share -37.98%1.9817.00%2.17532.60%2.018-20.06%6.60236.86%1.062-18.46%3.194-29.24%2.028-54.75%0.31984.48%8.259-22.79%0.776
Dividend per share
Currency Unit DKKDKKDKKDKKDKKDKKDKKDKKDKKDKK
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data